A lipolysis-focused recomposition stack pairing the GH fragment AOD-9604 with the GHRH analogue CJC-1295.
AOD-9604 is a fragment of growth hormone (the 176-191 region) studied for fat metabolism without the broader GH/IGF-1 effects, making it a targeted lipolysis tool. CJC-1295 adds a genuine GH-axis bump for the recomposition side.
This sits between the pure fat-loss stacks and the GH-secretagogue recomp stacks — fat-leaning but with some anabolic support. Evidence for AOD-9604's body-composition benefit in humans is modest; set expectations accordingly.
| Compound | Role | Dose | Frequency |
|---|---|---|---|
| AOD-9604 GH fragment; targeted lipolysis. | Primary | 250-500mcg | Once daily |
| CJC-1295 (without DAC) GHRH analogue; recomposition support. | Support | 100-300mcg per injection | 2-3 times daily (morning, post-workout optional, bedtime) |